FDA Approves a New Obesity Drug Poised to Dethrone Wegovy

Published on November 8, 2023

There’s officially a new and fierce competitor for Novo Nordisk’s Wegovy (semaglutide) when it comes to weight loss. On Wednesday, the Food and Drug Administration approved the drug tirzepatide, developed by Eli Lilly, as a treatment for obesity. The weekly injectable drug will be sold under the brand name Zepbound.

Read more...

Continue reading on website
Other news

Wes Ball's Old Tweets About a Zelda Movie Are Fascinating Hindsight

November 8, 2023
Yesterday, Nintendo and Sony Pictures teamed up to deliver the shocking news that they were working on a live action adaptation of The Legend of Zelda. Even more so, they’d found their director already in Maze Runner and Kingdom of the Planet of the Apes’ Wes Ball. But it turns out Ball has had a long, long time to…Read more...

A Decade Of GTA VI Speculation, Rumors, And Hijinks Will Soon Come To An End

November 8, 2023
On Wednesday, Rockstar Games officially confirmed that—after many years of waiting—the next Grand Theft Auto game will finally be revealed via a trailer in early December. People online are understandably going wild over the news and it marks the end of a bizarre era of endless speculation and hijinks.Read more...